Welcome to the new morningstar.co.uk! Learn more about the changes and how our new features help your investing success.

AXA Framlington Biotech Fund GBP Z Acc

Morningstar Rating™(Relative to Category)30/09/2019
 Morningstar ReturnMorningstar RiskMorningstar Rating™
3-YearAverageAverage3 star
5-YearAverageAbove Average3 star
10-Year*AverageAbove Average3 star
Overall*AverageAbove Average3 star
 
Click here to see our Methodology
1 Year Daily Volatility Chart (annualised)
  • AXA Framlington Biotech Fund GBP Z Acc
  • NASDAQ Biotechnology TR USD
%
Volatility Measurements30/09/2019
 
3-Yr Std Dev19.34 %
3-Yr Mean Return4.11 %
 
3-Yr Sharpe Ratio0.18
 
Modern Portfolio Statistics30/09/201930/09/2019
 Standard IndexBest Fit Index
 NASDAQ Biotechnology TR USD  NASDAQ Biotechnology PR USD
3-Yr Beta0.980.98
3-Yr Alpha-0.80-0.31
 
Advertisement
* This share class has performance data calculated prior to the inception date, 2012-04-16. This is based upon a simulated/extended track record, using the track record of AXA Framlington Biotech R Acc (ISIN: GB0031007254), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites